Scarica l'app Stockscreener
567.22
0.61%
3.42
Pre-mercato:
567.23
0.010
+0.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché REGN Giù?
Forum
Previsione
Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie
Regeneron Pharmaceuticals (REGN): Undervalued Innovator with Asymmetric Upside in 2025–2026 - AInvest
Regeneron Pharmaceuticals, Inc. $REGN Stock Position Lessened by Vident Advisory LLC - MarketBeat
Is a relief rally coming for Regeneron Pharmaceuticals Inc. holdersM&A Rumor & Safe Entry Zone Identification - Newser
Ieq Capital LLC Raises Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What makes Regeneron Pharmaceuticals Inc. stock price move sharplyJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser
Sanofi’s amlitelimab hits phase III endpoints in atopic dermatitis - BioWorld MedTech
Landscape Capital Management L.L.C. Takes Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron’s Strategic Visibility in Upcoming Investor Conferences: A Glimpse into Innovation and Growth - AInvest
Leading Biotech Regeneron Announces New Time for Morgan Stanley Global Healthcare Conference - Stock Titan
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Canada Pension Plan Investment Board - MarketBeat
Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory - MSN
Regeneron at Wells Fargo Conference: Strategic Insights on Growth - Investing.com
Transcript : Regeneron Pharmaceuticals, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 09 - MarketScreener
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Share Price Is Matching Sentiment Around Its Earnings - 富途牛牛
Can Regeneron Pharmaceuticals Inc. expand its profit marginsJuly 2025 Rallies & Reliable Entry Point Trade Alerts - khodrobank.com
Immuno-Oncology Q2 Earnings: Regeneron (NASDAQ:REGN) Simply the Best - Yahoo Finance
Is Regeneron Pharmaceuticals Inc. on track to beat earningsJuly 2025 Catalysts & Expert Curated Trade Setups - khodrobank.com
How high can Regeneron Pharmaceuticals Inc. stock goJuly 2025 Breakouts & AI Based Trade Execution Alerts - Newser
Magnetar Financial LLC Sells 96,608 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Momentum divergence signals in Regeneron Pharmaceuticals Inc. chart2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Regeneron Tumbles 2.44% as 640M in Trading Volume Ranks 144th in Market Activity - AInvest
Lansforsakringar Fondforvaltning AB publ Sells 1,751 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - Newser
Regeneron Pharmaceuticals’ Strategic Position in the 2025 Biotech Landscape - AInvest
Regeneron at Cantor Global Healthcare Conference: Strategic Growth and Challenges - Investing.com
Can Regeneron Pharmaceuticals Inc. reach all time highs this yearQuarterly Earnings Summary & Reliable Entry Point Trade Alerts - khodrobank.com
Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmaceutical, POINT Biopharma, Tavanta Therapeutics, Exelixis, Astellas Pharma Inc., Antev, ORCA Therapeutics, Regeneron Phar - Barchart.com
Sporadic Inclusion Body Myositis Market: Epidemiology, - openPR.com
The Manufacturers Life Insurance Company Purchases 41,826 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Te Ahumairangi Investment Management Ltd Purchases Shares of 1,412 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Key resistance and support levels for Regeneron Pharmaceuticals Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - Newser
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by GW Henssler & Associates Ltd. - MarketBeat
What candlestick patterns are forming on Regeneron Pharmaceuticals Inc.Market Risk Analysis & Growth Focused Entry Reports - Newser
How to track smart money flows in Regeneron Pharmaceuticals Inc.July 2025 Sector Moves & AI Enhanced Trading Alerts - Newser
Will Regeneron Pharmaceuticals Inc. outperform the marketOptions Play & Low Volatility Stock Recommendations - Newser
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - MSN
OMERS ADMINISTRATION Corp Has $2.75 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
How Is Regeneron’s Stock Performance Compared To Other Pharma Stocks? - Barchart.com
Regeneron Pharmaceuticals Inc. stock trend forecastJuly 2025 Movers & High Conviction Trade Alerts - Newser
Real time social sentiment graph for Regeneron Pharmaceuticals Inc. - Newser
Orion Investment Co Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What are Regeneron Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - khodrobank.com
Intraday pattern recognizer results for Regeneron Pharmaceuticals Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Regeneron: Drug Pricing Woes Notwithstanding, Due For A Major Comeback (NASDAQ:REGN) - Seeking Alpha
Wellington Management Group LLP Sells 131,415 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Kestra Advisory Services LLC Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Evercore ISI Maintains a Buy on Regeneron Pharmaceuticals (REGN) With a $750 PT - MSN
Tema Etfs LLC Has $2.73 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
COPD Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma - Barchart.com
Armistice Capital LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What the charts say about Regeneron Pharmaceuticals Inc. todayStock Surge & Long-Term Safe Investment Plans - Newser
Guggenheim Capital LLC Sells 4,547 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $781.00 - MarketBeat
1.37%
5.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):